4//SEC Filing
Shukla Sath 4
Accession 0000950170-24-092170
CIK 0001701108other
Filed
Aug 5, 8:00 PM ET
Accepted
Aug 6, 7:56 PM ET
Size
6.3 KB
Accession
0000950170-24-092170
Insider Transaction Report
Form 4
Shukla Sath
CEO & President
Transactions
- Sale
Common Stock
2024-08-02$1.32/sh−14,800$19,536→ 1,161,207 total - Sale
Common Stock
2024-08-05$1.31/sh−17,641$23,110→ 1,143,566 total
Footnotes (1)
- [F1]The reported transaction is a sale of common stock effected to cover tax withholding obligations in connection with the vesting of RSUs that were granted to the Reporting Person on August 1, 2023 pursuant to a "sell to cover" provision included in each RSU Agreement.
Documents
Issuer
Spero Therapeutics, Inc.
CIK 0001701108
Entity typeother
Related Parties
1- filerCIK 0001782817
Filing Metadata
- Form type
- 4
- Filed
- Aug 5, 8:00 PM ET
- Accepted
- Aug 6, 7:56 PM ET
- Size
- 6.3 KB